Prot# CLI-037: A Phase III Randomized Study of CLORETAZINE (VNP40101M) and Cytosine Arabinoside (AraC) in Patients with Acute Myeloid Leukemia in First Relapse

Project: Research project

Project Details

StatusFinished
Effective start/end date2/8/06 → 3/1/12

Funding

  • Ingenix Pharmaceutical Services, Inc. (CLI-037)
  • Vion Pharmaceuticals, Inc. (CLI-037)